Possible rivaroxaban antidote identified

Subject: Possible rivaroxaban antidote identified Tue Sep 20, 2011 7:14 pm

Amsterdam, the Netherlands (updated) - Results of a small study published online September 6, 2011 in Circulation show that prothrombin complex concentrate (PCC) appears to be an effective antidote for rivaroxaban that could be used to stop or prevent serious bleeding in patients taking this new anticoagulant. However, the same study showed that PCC has no influence on dabigatran

(read the whole article)

Subject: Re: Possible rivaroxaban antidote identified Tue Sep 20, 2011 7:19 pm

Figures, Pradax (Pradaxa) is approved by FDA/HealthCan/EDA but has no "antidote" but here we have rivaroxaban, WITH an antidote but not approved by the FDA/HC/EDA. scratch

» Rivaroxaban update
» FDA will argue against rivaroxaban's approval...
» Xarelto (rivaroxaban) vs Pradaxa (dabigatran)
» UPDATE: FDA: Proposed Drug Rivaroxaban Has Bleeding Risk